IMRN
Price
$1.90
Change
+$0.15 (+8.57%)
Updated
Apr 3, 01:30 PM (EDT)
Capitalization
9.15M
55 days until earnings call
VYGR
Price
$3.24
Change
-$0.17 (-4.99%)
Updated
Apr 3, 01:29 PM (EDT)
Capitalization
188.26M
40 days until earnings call
Ad is loading...

IMRN vs VYGR

Header iconIMRN vs VYGR Comparison
Open Charts IMRN vs VYGRBanner chart's image
Immuron
Price$1.90
Change+$0.15 (+8.57%)
Volume$382
Capitalization9.15M
Voyager Therapeutics
Price$3.24
Change-$0.17 (-4.99%)
Volume$400
Capitalization188.26M
IMRN vs VYGR Comparison Chart
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. VYGR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a Hold and VYGR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IMRN: $1.75 vs. VYGR: $3.41)
Brand notoriety: IMRN and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRN: 74% vs. VYGR: 106%
Market capitalization -- IMRN: $9.15M vs. VYGR: $188.26M
IMRN [@Biotechnology] is valued at $9.15M. VYGR’s [@Biotechnology] market capitalization is $188.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than IMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 2 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • IMRN’s TA Score: 2 bullish, 2 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IMRN and VYGR are a good buy in the short-term.

Price Growth

IMRN (@Biotechnology) experienced а -2.78% price change this week, while VYGR (@Biotechnology) price change was -6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.00%. For the same industry, the average monthly price growth was -10.08%, and the average quarterly price growth was -14.20%.

Reported Earning Dates

IMRN is expected to report earnings on May 28, 2025.

VYGR is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($188M) has a higher market cap than IMRN($9.15M). IMRN YTD gains are higher at: 2.941 vs. VYGR (-39.859). IMRN has higher annual earnings (EBITDA): -7.35M vs. VYGR (-78.56M). VYGR has more cash in the bank: 267M vs. IMRN (7.74M). VYGR has higher revenues than IMRN: VYGR (80M) vs IMRN (6.54M).
IMRNVYGRIMRN / VYGR
Capitalization9.15M188M5%
EBITDA-7.35M-78.56M9%
Gain YTD2.941-39.859-7%
P/E RatioN/A6.00-
Revenue6.54M80M8%
Total Cash7.74M267M3%
Total DebtN/A43.7M-
FUNDAMENTALS RATINGS
IMRN vs VYGR: Fundamental Ratings
IMRN
VYGR
OUTLOOK RATING
1..100
274
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
6392
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
n/a45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMRN's Valuation (30) in the Biotechnology industry is in the same range as VYGR (39). This means that IMRN’s stock grew similarly to VYGR’s over the last 12 months.

IMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VYGR (100). This means that IMRN’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as IMRN (97). This means that VYGR’s stock grew similarly to IMRN’s over the last 12 months.

IMRN's Price Growth Rating (63) in the Biotechnology industry is in the same range as VYGR (92). This means that IMRN’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for IMRN (100). This means that VYGR’s stock grew significantly faster than IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMRNVYGR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 29 days ago
90%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 29 days ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 22 days ago
79%
Declines
ODDS (%)
Bearish Trend about 1 month ago
89%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 29 days ago
76%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 29 days ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QLSGX25.500.49
+1.96%
Federated Hermes MDT Small Cap Growth R6
JFNSX64.300.75
+1.18%
Janus Henderson Global Life Sciences S
IDPIX63.01N/A
N/A
ProFunds Industrial Ultra Sector Inv
ASQAX14.40N/A
N/A
American Century Small Company A
THOIX38.96N/A
N/A
Thornburg Global Opportunities I